Dobutamine

Manufacturer: PFIZER INC. (HOSPIRA)
Regulated product
Non-Returnable Product
List Price: from $20.29 EA
View All Specs
Manufacturer: PFIZER INC. (HOSPIRA)
View All Specs
Catalog page # 351
Product description:

Due to manufacturer requirements, this product is no longer available to be ordered in the EACH quantity. Learn more. 

 

Always follow your local protocols regarding product use.

➤ License Authorization Form (LAF) Required


Please note: These items are available from multiple manufacturers including Hospira Worldwide, Meridian Medical Technologies and Other Manufacturers

You are unable to select more than your available quota at this time. Please contact your administrator for assistance.
Refine results
Strength
Color
pH Range
Life Stage
NDC Code
Storage Requirements
Uses
Latex Free
Total Items Selected
Total Items Selected
Dobutamine Vial, 250mg, 20mL
Dobutamine/D5W Bag, 250mg, 250mL
*Case Quantity* Dobutamine/D5W Bag, 500mg, 250mL
Product # 234401 2346-32 2347-32
Strength 12.5mg/mL 250mg/20mL 1mg/mL 250mg/250mL 2mg/mL 500mg/250mL
Color Clear Colorless Colorless
Application Type Human Prescription Drug Human Prescription Drug Human Prescription Drug
Purpose Beta-adrenergic Agonist Beta-adrenergic Agonist Beta-adrenergic Agonist
Route of Administration Intravenous Intravenous Intravenous
pH Range 3.3 (2.5 to 5.5) 2.5 to 5.5 2.5 to 5.5
Life Stage 20mL 250mL 250mL
NDC Code 00409-2344-01 0409-2346-32 0409-2347-32
Grade Usp Usp Usp
Sterile Sterile Sterile Sterile
Formulation Solution Solution Solution
Storage Requirements 20 to 25°C, USP Controlled Room Temperature 20 to 25°C USP Controlled Room Temperature 20 to 25°C USP Controlled Room Temperature
Solubility Water Soluble Water Soluble Water Soluble
Uses Dobutamine Injection, USP is Indicated when Parenteral Therapy is Necessary for Inotropic Support in the Short-Term Treatment of Adults with Cardiac Decompensation due to Depressed Contractility Resulting Either from Organic Heart Disease or from Cardiac Surgical Procedures Dobutamine in 5% Dextrose Injection, USP is Indicated when Parenteral Therapy is Necessary for Inotropic Support in the Short-Term Treatment of Patients with Cardiac Decompensation Due to Depressed Contractility Resulting Either from organic Heart Disease or from Cardiac Surgical Procedures Dobutamine in 5% Dextrose Injection, USP is Indicated when Parenteral Therapy is Necessary for Inotropic Support in the Short-Term Treatment of Patients with Cardiac Decompensation Due to Depressed Contractility Resulting Either from organic Heart Disease or from Cardiac Surgical Procedures
Latex Free Yes Yes
Active Ingredient Dobutamine, Hydrochloride Dobutamine, Hydrochloride Dobutamine, Hydrochloride